Impact of Sperm Oxidative Stress on Embryonic Parameters and Pregnancy Success During Intrauterine Insemination and in Vitro Fertilization

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Oxidative stress (OS) is characterized by an imbalance between the production of reactive oxygen species (ROS) and the ability of the body to eliminate them. Such an imbalance can lead to lipid peroxidation, DNA damage and cell apoptosis. Studies have suggested that infertile men are more likely to have high concentrations of ROS in their seminal plasma. The investigators hypothesize that a high level of oxidative stress (OS) in patients with abnormal sperm parameters could influence fertilization and / or pregnancy success. Our first goal is to compare OS levels to semen parameters, as defined by the World Health Organization in 2010, as well as DNA fragmentation and chromatin decondensation in sperm. Our second objective is to compare OS levels in sperm to fertilization and blastulation rates at first, and then measure the impact of OS levels on pregnancy success, both in intrauterine insemination (IUI) and in vitro fertilization (IVF). Sperm samples from men in 3 groups will be analyzed: a group of fertile men with confirmed paternity (n = 50), a group of men in IVF (n = 100) and a group of men in their first three cycles of IUI (n = 100). The static oxidation reduction index (sORP) will be measured by the MiOXSYS © system, a rapid sperm analysis system using electrochemical technology. A small portion of the fresh sperm sample will be deposited on a MiOXSYS sensor and the ORP will be measured. Sperm ROS will also be measured using the CellROX Deep Red probe. The sperm parameters will be measured by the techniques used routinely in the Fertilys Reproductive Health Center andrology lab. Regarding couples in IVF, fertilization and blastulation rates, embryo quality and pregnancy success will be noted. Pregnancy success will be noted for IUI couples. If the usefulness of sORP levels in predicting pregnancy and its outcome is demonstrated, it could be a new marker in the diagnosis of male infertility and act as a guide for clinicians to apply appropriate treatment.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 40
View:

• All men with confirmed paternity aged 18 to 40 years, agreeing to participate in the study and having signed the consent form.

• All patients aged 18 to 40 using IVF or their first cycle of IUI at the Fertilys Reproductive Health Center, agreeing to participate in the study and having signed the consent form.

Locations
Other Locations
Canada
Fertilys
RECRUITING
Laval
Contact Information
Primary
Fabien Joao, M.Sc.
fabien.joao@fertilys.org
4509349146
Backup
Cécile Adam, PhD
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 250
Treatments
Confirmed paternity
Sperm sample from men with confirmed paternity
Intrauterine insemination
Sperm sample from men in intrauterine insemination process
In vitro fertilization
Sperm sample from men in in vitro fertilization process
Related Therapeutic Areas
Sponsors
Leads: Fertilys

This content was sourced from clinicaltrials.gov